|
Novartis International AG is a pharmaceutical MNC that is based in Basel, Switzerland. They are one of the strongest contenders of the growing pharmaceutical market. They occupy the sixth position worldwide in terms of sales volume of healthcare products. In 2010, the company earned total revenue of US$ 50.624 billion. In 2009, they maintained a profit margin of 20%.
Company profile
Novartis produces a range of healthcare products that include pharmaceuticals, over-the-counter and generic drugs, eye care products, vaccines, diagnostic equipments, and consumer healthcare products.
The company was established in 1996 and at the time of its inception, only 45% of the company’s earning was generated from sale of medicines. But now the company has shifted its focus to concentrate on the fast growing pharmaceutical industry.
The company is highly recognized for supporting innovation and groundbreaking researches in drug manufacturing. They occupy the leading position in producing both patented medicine and generic drugs. Novartis is dedicated to offer improved healthcare solutions to patients. The company holds the key position worldwide in the following segments of healthcare:
-
Pharmaceuticals: Innovations have been undertaken to offer patent-protected drugs.
-
Sandoz: Generic medicines and biosimilars that are produced for mass consumption and therefore are moderately priced.
-
Consumer health: Medication for animals and also medicines that the patient can administer himself.
-
Alcon: Leading brand in producing eye care products.
-
Vaccination and diagnostics: Lifesaving vaccinations and diagnostic tools are produced to offer better medical care and prevention.
-
Over-the-Counter (OTC): The OTC division of the company is known for producing diverse products in areas of analgesics, cough and cold medicines, anti-allergic, gastrointestinal, dermatological medication, smoking-cessation medications and mineral supplements.
The history of Novartis can be traced to the period before 1996 when J. R. Geigy Ltd, CIBA and Sandoz were three different entities. In 1996, the company was created from the merger of Ciba-Geigy and Sandoz Laboratories. Both the companies were of Swiss origin.
Novartis in India
The Indian division of the company is known as Novartis India Limited. It is one of the leading pharmaceutical brands in the country with a market capital of INR 22525.9697256 million. The Indian unit was incorporated in 1947. In the financial year that ended in March 2011, the net profit for the company stood at INR 1466.726 million.
Career at Novartis
Undoubtedly, the company offers rewarding career options to young professionals and for that they encourage candidates to submit their resumes on their website. Most of the opportunities are available in the field of research and development. However, career options are also available in the following categories as well:
-
Sales and marketing
-
Logistics
-
Commercial and general management
-
Corporate affairs
-
Finance
-
Human resource
-
Legal and intellectual property
-
Corporate strategy
-
Development and medical
-
Information technology
-
Facilities and administration
They have several teams of researchers all over the world who are constantly striving to produce groundbreaking researches in the fields of medication. Researchers can find job opportunities in the following departments of R&D:
The Novartis Institutes for BioMedical Research (NIBR): It performs researches in the areas of cardiovascular and metabolic diseases, oncology, infectious diseases, ophthalmology, biologics and the like.
Novartis Molecular Diagnostics: This division plays the supportive role in helping the company become a world leader in pharmaceutical manufacturing. They help with diagnostics, identifying responders and improving favorable outcomes. They work in divisions of nucleic acid-based assay development, bioinformatics and biostatistics, global diagnostic development programs, and global marketing and market access.
Novartis Institute for Tropical Diseases (NITD): This division has specialized in offering research solutions to tropical diseases in various developing countries. The team of more than 100 researchers have come together to offer solutions to tropical diseases and endemics.
Last Updated: 12/01/11
| 
